Safety and Efficacy of a Dual Chamber Implantable Cardioverter Defibrillator Capable of Slow Ventricular Tachycardia Discrimination: A Randomized Study

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 12, 2003, Pages 2275-2282

  Mletzko, Ralph ^a   Aliot, Etienne ^b   Seidl, Karlheinz ^c   Lavergne, Thomas ^d   Mabo, Philippe ^e   Hohnloser, Stefan ^f   Böcker, Dirk ^g   Schoels, Wolfgang ^h   Sadoul, Nicolas ^b  

^a Herz Kreislaufklinik ^*  (Germany)

^b Hopital Barbois   (France)

^c Department of Cardiology   (Germany)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e Ctr Cardio Pneumonologique P   (France)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g Innere Medizin A   (Germany)

^h UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Arrhythmia detection algorithm; Implantable cardioverter defibrillator; Supraventricular tachycardia; Ventricular tachycardia

Indexed keywords

AMIODARONE;

ADULT; AGED; ALGORITHM; ARTICLE; COMPUTER PROGRAM; DEFIBRILLATOR; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZATION; RISK; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; SINUS TACHYCARDIA; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

ALGORITHMS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 0346101475     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2003.00359.x     Document Type: Article

References (21)

1. Rosenqvist M, Beyer T, Block M, et al. On behalf of the European 7219 Jewel ICD Investigators. Adverse events with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation 1998; 98:663-670.
2. Nunain SO, Roelke M, Trouton T, et al. Limitations and late complications of thirdgeneration automatic cardioverter-defibrillators. Circulation 1995; 91:2204-2213.
3. Hammill SC, Friedmann PA. Shocking sinus. How inappropriate! Cardiovasc Electrophysiol 2000; 11:1116-1118.
4. Schuger CD, Jackson K, Russel TS, et al. Atrial sensing to augment ventricular tachycardia detection by the automatic implantable cardioverter defibrillator. PACE 1988; 11:1456-1464.
5. Jung W, Lüderitz B. Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet 1997; 349:853-854.
6. Nair M, Saoudi N, Kroiss D, et al. For the participating centers of the Automatic Recognition of Arrhythmia Study Group. Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Circulation 1997; 95:967-973.
7. Dijkman B, Wellens HJ. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000; 11:1105-1115.
8. Swerdlow CD, Chen PS, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994; 23:1342-1355.
9. Swerdlow CD, Ahern T, Chen PS, et al. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994; 24:416-424.
10. Bänsch D, Castrucci M, Böcker D, et al. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators. incidence, prediction and significance. JACC 2000; 36:557-565.
11. Lavergne T, Daubert JC, Chauvin M, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20:182-188.
12. Sadoul N, Jung W, Jordaens L, et al. Diagnostic performance of a dual chamber cardioverter defibrillator programmed with nominal settings: A European prospective study. J Cardiovasc Electrophysiol 2002; 13:25-32.
13. Schoels W, Swerdlow CD, Jung W, et al. The Worldwide Jewel AF Investigators. Worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001; 12:521-528.
14. Wilkoff BL, Kuhlkamp V, Volosin K, et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001; 103:381-386.
15. Luceri RM, for the Photon DR Clinical Investigators. Initial clinical experience with a dual chamber rate responsive implantable cardioverter defibrillator. PACE 2000; 23:1986-1988.
16. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002; 87:488-493.
17. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105:589-594.
18. Duru F, Buchi S, Klaghofer R, et al. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart 2001; 85:375-379.
19. Sears SF, Todaro JF, Urizar G, et al. Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers. PACE 2000; 23:939-945.
20. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104:796-801.
21. Weber M, Block M, Bansch D, et al. Antitachycardia pacing for rapid VT during ICD charging: A method to prevent ICD shocks. PACE 2001; 24:345-351.